| JUND |
bone marrow-derived macrophages |
lipid A 0 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
lipid A 15 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
lipid A 30 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
lipid A 60 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
lipid A 120 min |
Permissive
Robust
|
Mus musculus |
GSE99895
...
|
MA0491.2
...
|
| JUND |
pre-activated CD8+ T cells |
Genotype: wildtype Strain: C57BL/6 Tissue: spleen Treament: stimulated ex vivo with plate-bound anti-CD3 and anti-CD28 antibodies |
Permissive
Robust
|
Mus musculus |
GSE77857
...
|
MA0491.2
...
|
| JUND |
pre-activated CD8+ T cells |
Genotype: Bach2-/- Strain: C57BL/6 Tissue: spleen Treament: stimulated ex vivo with plate-bound anti-CD3 and anti-CD28 antibodies |
Permissive
Robust
|
Mus musculus |
GSE77857
...
|
MA0491.2
...
|
| JUND |
primary fibroblasts |
Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0491.2
...
|
| JUND |
primary fibroblasts |
Treatment: starved with 0.5% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0491.2
...
|
| JUND |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0491.2
...
|
| JUND |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Passage: 3 Genotype: wildtype Strain:C57BL/6J Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0491.2
...
|
| JUND |
primary fibroblasts |
Treatment:starved with 0.5% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0491.2
...
|
| JUND |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0491.2
...
|
| JUND |
primary fibroblasts |
Treatment:starved with 0.5% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0491.2
...
|
| JUND |
primary fibroblasts |
Treatment: 90min stimulation with 15% serum media Strain: SPRET/EiJ Genotype: wildtype Age: E13.5-E14.5 |
Permissive
Robust
|
Mus musculus |
GSE83295
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl6; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; Genotype: PPARg knockout; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
Sex: male; Strain:C57Bl/6EiJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
Sex: male; Strain:Balb/cJ; Treatment: KLA for 1 hr; Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0491.2
...
|
| JUND |
bone marrow-derived macrophages |
Sex: male; Strain:Balb/cJ; Treatment: PBS (Veh); Source: thioglycollate elicited macrophage cells; |
Permissive
Robust
|
Mus musculus |
GSE111854
...
|
MA0491.2
...
|
| JUND |
HT29 (colon adenocarcinoma) |
DSMO |
Permissive
Robust
|
Homo sapiens |
GSE77039
|
MA0491.2
...
|
| JUND |
hFOB 1.19 (fetal osteoblast) |
DIFF |
Permissive
Robust
|
Homo sapiens |
GSE82295
|
MA0492.1
|
| JUND |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BGK
|
MA0491.2
...
|
| JUND |
WA01 (H1, human embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BKP
|
MA0491.2
...
|
| JUND |
HCT-116 (colon carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BSA
|
MA0491.2
...
|
| JUND |
SK-N-SH (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BSK
|
MA0491.2
...
|
| JUND |
MCF7 (Invasive ductal breast carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BSU
|
MA0491.2
...
|
| JUND |
T47D (invasive ductal carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BVO
|
MA0491.2
...
|
| JUND |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000DJX
|
MA0491.2
...
|
| JUND |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000DYS
|
MA0491.2
...
|
| JUND |
WA01 (H1, human embryonic stem cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EBZ
|
MA0491.2
|
| JUND |
HeLa S3 (cervical adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EDH
|
MA0491.2
...
|
| JUND |
HepG2 (hepatoblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EEI
|
MA0491.2
...
|
| JUND |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EGN
|
MA0491.2
...
|
| JUND |
SK-N-SH (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EIB
|
MA0491.2
...
|
| JUND |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EYV
|
MA0491.2
...
|
| JUND |
GM12878 (female B-cells lymphoblastoid cell line) |
|
Permissive
Robust
|
Homo sapiens |
GSE30399
...
|
MA0491.2
...
|
| JUND |
CH12.LX (Mouse lymphoma) |
|
Permissive
Robust
|
Mus musculus |
ENCSR000ERR
...
|
MA0491.2
...
|
| JUND |
MEL cell line |
|
Permissive
Robust
|
Mus musculus |
ENCSR000ETZ
...
|
MA0491.2
...
|
| JUND |
Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE39756
...
|
MA0491.2
...
|
| JUND |
STHdhQ7 (striatal cells) |
|
Permissive
Robust
|
Mus musculus |
GSE43429
...
|
MA0491.2
...
|
| JUND |
STHdhQ111 (striatal cells) |
|
Permissive
Robust
|
Mus musculus |
GSE43429
...
|
MA0491.2
...
|
| JUND |
CD8+ T-cells |
|
Permissive
Robust
|
Mus musculus |
GSE54191
...
|
MA0491.2
...
|
| JUND |
3T3-L1-derived adipocytes |
|
Permissive
Robust
|
Mus musculus |
GSE56745
...
|
MA0491.2
...
|
| JUND |
Calu-3 (lung adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE85401
...
|
MA0491.2
...
|
| JUND |
Junb+/+ CD4cre Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE98412
...
|
MA0491.2
...
|
| JUND |
Junb fl/fl CD4cre Th17-cells |
|
Permissive
Robust
|
Mus musculus |
GSE98412
...
|
MA0491.2
...
|
| JUND |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR837GTK
|
MA0491.2
...
|
| JUND |
liver |
|
Permissive
Robust
|
Homo sapiens |
ENCSR196HGZ
|
MA0491.2
...
|
| JUND |
PC3(bone mets prostate adenocarcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE29808
|
MA0491.2
...
|
| JUND |
|
|
Permissive
Robust
|
Homo sapiens |
GSE59021
|
MA0491.2
...
|
| JUND |
|
|
Permissive
Robust
|
Homo sapiens |
GSE61369
|
MA0491.2
...
|
| JUND |
GP5d (colon adenocarcinoma) |
SIRAD21 |
Permissive
|
Homo sapiens |
GSE51234
|
MA0492.1
|
| JUND |
GP5d (colon adenocarcinoma) |
|
Permissive
|
Homo sapiens |
GSE51234
|
MA0492.1
|
